Previous Close | 22.20 |
Open | 22.20 |
Bid | 22.20 x N/A |
Ask | 23.60 x N/A |
Day's Range | 22.20 - 22.20 |
52 Week Range | 12.60 - 25.60 |
Volume | |
Avg. Volume | 3 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Bicycle Therapeutics ( NASDAQ:BCYC ) First Quarter 2024 Results Key Financial Results Revenue: US$19.5m (up 299% from...
Comparison with Analyst Estimates and Strategic Developments
CAMBRIDGE, England & BOSTON, May 02, 2024--Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today reported recent business progress and financial results for the first quarter ended March 31, 2024.